🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
TBP
$TBPH
🔒 US EquitiesTheravance Biopharma Inc
AVG HISTORICAL GAP
-0.16%
MAX GAP RECORD
-10.51%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $TBPH
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$TBPH
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Aug 10, 2026 Earnings Release 2026-08-10 (UNDETERMINED) |
+0.00%
|
| May 07, 2026 Earnings Release 2026-05-07 (AFTER CLOSE) |
-1.41%
|
| Mar 19, 2026 Earnings Release 2026-03-19 (BEFORE OPEN) |
-1.52%
|
| Nov 10, 2025 Earnings Release 2025-11-10 (AFTER CLOSE) |
+3.25%
|
| Aug 12, 2025 Earnings Release 2025-08-12 (AFTER CLOSE) |
+0.59%
|
| May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE) |
-0.30%
|
| Feb 26, 2025 Earnings Release 2025-02-26 (AFTER CLOSE) |
+8.81%
|
| Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE) |
+6.29%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.7%
Bullish Gaps (5)
Bearish Gaps (5)
Neutral / Flat (4)
📖 Intelligence Summary
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the following geographical segments: U.S. and Europe. The company was founded in July 2013 and is headquartered in South San Francisco, CA.
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗